A structured approach for assessing the current status, identifying opportunities, and formulating strategies for implementing the mission of UWCCC ensures effective and well-coordinated use of Core Grant resources, institutional discretionary support and philanthropic funds. Through UWCCC program evaluation and planning efforts, a number of reviews, evaluations and retreats during the current grant period have resulted in strategic initiatives for UWCCC Scientific Programs and Shared Resources, organization and infrastructure support for Administration, focused enhancements to the Cancer Service Line, regional clinical plans and activities and Community Advisory Board priorities. These have occurred through regular strategic planning meetings of individual focus groups/committees of the Cancer Service Line;the UWCCC Community Advisory Board;the UWCCC Executive Committee, Leadership Group and EAB;and the annual UWCCC scientific retreat, as well as ad hoc review groups evaluating focused areas such as administrative organization, cancer control, research imaging, genetics and informatics. Engaging critical review by peers is an important component of evaluation and forms the basis for planning that will focus future directions. The Director, with the advice of the Executive Committee, manages all planning and development money centrally in order to maintain the ability to account for its expenditure and evaluate its impact.
The UW Carbone Cancer Center has a well-established planning and evaluation process which includes an External Advisory Board, yearly retreats, and regular Scientific Program meetings to assure that the UWCCC is addressing the mission of the National Cancer Institute.
|Shen, Sida; Jiang, Dawei; Cheng, Liang et al. (2017) Renal-Clearable Ultrasmall Coordination Polymer Nanodots for Chelator-Free 64Cu-Labeling and Imaging-Guided Enhanced Radiotherapy of Cancer. ACS Nano 11:9103-9111|
|Xie, Angela W; Binder, Bernard Y K; Khalil, Andrew S et al. (2017) Controlled Self-assembly of Stem Cell Aggregates Instructs Pluripotency and Lineage Bias. Sci Rep 7:14070|
|Goel, Shreya; Ni, Dalong; Cai, Weibo (2017) Harnessing the Power of Nanotechnology for Enhanced Radiation Therapy. ACS Nano 11:5233-5237|
|Zhang, Ranran; Hardin, Heather; Huang, Wei et al. (2017) MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR. Endocr Pathol 28:7-12|
|Prabakaran, Prashanth J; Javaid, Amal M; Swick, Adam D et al. (2017) Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition. Clin Cancer Res 23:6044-6053|
|Strekalova, Elena; Malin, Dmitry; Rajanala, Harisha et al. (2017) Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression. Breast Cancer Res Treat 163:435-447|
|Garcia-Peterson, Liz Mariely; Ndiaye, Mary Ann; Singh, Chandra K et al. (2017) SIRT6 histone deacetylase functions as a potential oncogene in human melanoma. Genes Cancer 8:701-712|
|Koziolová, Eva; Goel, Shreya; Chytil, Petr et al. (2017) A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging. Nanoscale 9:10906-10918|
|Zhao, Lei; Li, Jun; Fu, Yingmei et al. (2017) Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration. J Neuroinflammation 14:14|
|Zhan, Yonghua; Shi, Sixiang; Ehlerding, Emily B et al. (2017) Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging. ACS Appl Mater Interfaces 9:38304-38312|
Showing the most recent 10 out of 1351 publications